Legacy Advisory Services’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$596K Buy
4,099
+2
+0% +$276 0.43% 45
2026
Q2
$526K Sell
4,097
-259
-6% -$30.3K 0.37% 29
2026
Q1
$524K Buy
+4,356
New +$503K 0.4% 24
2025
Q2
– Sell
-4,494
Closed -$403K – 49
2025
Q1
$403K Buy
4,494
+926
+26% +$86.5K 0.34% 37
2024
Q4
$355K Hold
3,568
– – 0.3% 43
2024
Q3
$405K Hold
3,568
– – 0.35% 40
2024
Q2
$442K Hold
3,568
– – 0.4% 35
2024
Q1
$471K Sell
3,568
-60
-2% -$7.4K 0.45% 32
2023
Q4
$396K Buy
+3,628
New +$377K 0.42% 32

Other funds holding MRK

Legacy Advisory Services's MRK Position: Q3 2026 in Review

Legacy Advisory Services increased its Merck (MRK) stake by 0.05% in Q3 2026, buying an estimated $276 and bringing the position to 4,099 shares worth $596K. The position accounts for 0.43% of the portfolio, ranked #45.

Legacy Advisory Services first reported a position in MRK in Q4 2023 and has held it in 9 quarters since. 1,277 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Legacy Advisory Services held 4,099 shares of Merck worth $596K as of Q3 2026.
  • Legacy Advisory Services bought 2 Merck shares in Q3 2026, an estimated $276.
  • Merck made up 0.43% of Legacy Advisory Services's portfolio in Q3 2026, its #45 holding.
  • Legacy Advisory Services first reported a position in Merck in Q4 2023 and has held it in 9 quarters since.
  • 1,277 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Legacy Advisory Services's 13F filing for Q3 2026, filed 20 Oct 2026.